Community screening for cardiovascular risk factors and levels of treatment in a rural Maori cohort

Australian and New Zealand Journal of Public Health

Volumn 35, Issue 6, 2011, Pages 517-523

  Faatoese, Allamanda F ^a   Pitama, Suzanne G ^b   Gillies, Tawhirimatea W ^b   Robertson, Paul J ^b   Huria, Tania M ^b   Tikao Mason, Karen N ^b   Doughty, Rob N ^c   Whalley, Gillian A ^d   Mark Richards, A ^a   Troughton, Richard W ^a   Sheerin, Ian G ^b   Elisabeth Wells, J ^b   Cameron, Vicky A ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

^d UNITEC INSTITUTE OF TECHNOLOGY   (New Zealand)

Author keywords

Cardiovascular risk factors; Cardiovascular screening; Indigenous health; M ori; Rural health

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; FEMALE; HEALTH; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MALE; MASS SCREENING; MIDDLE AGED; NEW ZEALAND; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREVALENCE; RISK FACTOR; SMOKING; STATISTICS;

ADULT; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; MALE; MASS SCREENING; MIDDLE AGED; NEW ZEALAND; OBESITY; PREVALENCE; RISK FACTORS; RURAL HEALTH; SMOKING;

EID: 84856020003     PISSN: 13260200     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1753-6405.2011.00777.x     Document Type: Article

References (32)

1. Ajwani S, Blakely T, Robson B, Tobias M, Bonne M. Decades of Disparity: Ethnic Mortality Trends in New Zealand 1980-1999. Wellington (NZ): New Zealand Ministry of Health; 2003.
2. Bramley D, Riddell T, Crengle S, Curtis E, Harwood M, Nehua D, et al. A call to action on Maori cardiovascular health. N Z Med J [Internet]. 2004;117(1197). PubMed PMID: 15326510.
3. National Health Committee. Rural Health: Challenges of Distance; Opportunities for Innovation. Wellington (NZ): New Zealand Ministry of Health; 2010.
4. Hay D. Cardiovascular Disease in New Zealand, 2004. NHF Technical Report No.: 82. Auckland (NZ): National Heart Foundation of New Zealand; 2004.
5. Riddell T, Jackson R, Wells S, Broad J, Bannink L. Assessing Maori/non-Maori differences in cardiovascular disease risk and risk management in routine primary care practice using web-based clinical decision support: (PREDICT CVD-2). N Z Med J [Internet]. 2007;120(1250). PubMed PMID: 17339901.
6. Gentles D, Metcalf P, Dyall L, Scragg R, Black P, Schaaf D, et al. Blood pressure prevalences and levels for a multicultural population in Auckland, New Zealand: results from the Diabetes, Heart and Health Survey 2002/2003. N Z Med J [Internet]. 2006;119(1245). PubMed PMID: 17146492.
7. Gentles D, Metcalf P, Dyall L, Scragg R, Sundborn G, Schaaf D, et al. Serum lipid levels for a multicultural population in Auckland, New Zealand: results from the Diabetes, Heart and Health Survey (DHAH) 2002-2003. N Z Med J [Internet]. 2007;120(1265). PubMed PMID: 18264180.
8. Gentles D, Metcalf P, Dyall L, Sundborn G, Schaaf D, Black P, et al. Metabolic syndrome prevalance in a multicultural population in Auckland, New Zealand. N Z Med J [Internet]. 2007;120(1248). PubMed PMID: 17277815.
9. Metcalf P, Scragg R, Schaaf D, Dyall L, Black P, Jackson R. Trends in major cardiovascular risk factors in Auckland, New Zealand: 1982 to 2002-2003. N Z Med J [Internet]. 2006;119(1245). PubMed PMID: 17146483.
10. Sundborn G, Metcalf P, Scragg R, Schaaf D, Dyall L, Gentles D, et al. Ethnic differences in the prevalence of new and known diabetes mellitus, impaired glucose tolerance, and impaired fasting glucose. Diabetes, Heart and Health Survey (DHAH) 2002-2003, Auckland New Zealand. N Z Med J [Internet]. 2007;120(1257). PubMed PMID: 17632597.
11. Ministry of Health. A Portrait of Health. Key Results of the 2006/2007 New Zealand Health Survey. Wellington (NZ): Government of New Zealand; 2008.
12. Prior I, Rose B, Davidson F. Metabolic maladies in New Zealand Maoris. BMJ. 1964;1:1065-9.
13. Tobias M, Taylor R, Yeh L-C, Huang K, Mann S, Sharpe N. Did it fall or was it pushed? The contribution of trends in established risk factors to the decline in premature coronary heart disease mortality in New Zealand. Aust N Z J Public Health. 2008;32(2):117-25. (Pubitemid 351577871)
14. Pitama S, Wells J, Faatoese A, Tikao-Mason K, Robertson P, Huria T, et al. A community cohort study of heart disease in New Zealand with two indigenous samples (rural and urban) and an urban non-indigenous sample: Design, methods, response rates and referral after baseline screening. Submitted to Aust N Z J Public Health. 2011;35:249-55.
15. Wallace T, Levy J, Matthews D. Use and abuse of HOMA modeling. Diabetes Care. 2004;27:1487-95. (Pubitemid 38680001)
16. Stern S, Williams K, Ferrannini E, De Fronzo R, Bogardus C, Stern M. Identification of individuals with insulin resistance using routine clinical measurements. Diabetes. 2005;54(2):333-9.
17. McAuley K, Williams S, Mann J, Walker R, Lewis-Barned N, Temple L, et al. Diagnosing insulin resistance in the general population. Diabetes Care. 2001;24(3):460-4. (Pubitemid 32198413)
18. New Zealand Guidelines Group. New Zealand Cardiovascular Guidelines Handbook: A Summary Resource for Primary Care Practitioners. 2nd ed. Wellington (NZ): New Zealand Ministry of Health; 2009.
19. Tipene-Leach D, Pahau H, Joseph N, Coppell K, McAuley K, Booker C, et al. Insulin resistance in a rural Maori community. N Z Med J [Internet]. 2004;117(1207). PubMed PMID: 15608803.
20. Beaglehole R, Foulkes M, Prior I, Eyles E. Cholesterol and mortality in New Zealand Maoris. BMJ. 1980;280(6210):285-7. (Pubitemid 10213082)
21. Ross J, Hamlin M. Maori physical activity: A review of an indigenous population's participation. Health Promot J Austr. 2007;18(1):7376.
22. Ministry of Health. Tobacco Trends 2008: A Brief Update of Tobacco Use in New Zealand. Wellington (NZ): Government of New Zealand; 2009.
23. Wang T, Vassan R. Epidemiology of Uncontrolled Hypertension in the United States. Circulation. 2005;112:1651-62. (Pubitemid 41324528)
24. Scragg R, Baker J, Metcalf P, Dryson E. Hypertension and its treatment in a New Zealand multicultural workforce. N Z Med J [Internet]. 1993;106(954):147-50. PubMed PMID: 8479658. (Pubitemid 23244156)
25. National Cholesterol Education Program (NCEP) Expert Panel. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation. 2002;106(25):3143-421.
26. Rafter N, Connor J, Hall J, Jackson R, Martin I, Parag V, et al. Cardiovascular medications in primary care: treatment gaps and targeting by absolute risk. N Z Med J [Internet]. 2005;118(1223). PubMed PMID: 16224500.
27. Elley C, Kenealy T, Robinson E, Bramley D, Selak V, Drury P, et al. Cardiovascular risk management of different ethnic groups with type 2 diabetes in primary care in New Zealand. Diabetes Res Clin Pract. 2008;79:468-73. (Pubitemid 351284494)
28. Wells S, Kerr A, Broad J, Riddell T, Kenealy T, Jackson R. The impact of New Zealand CVD risk chart adjustments for family history and ethnicity on eligibility for treatment (PREDICT CVD-5). N Z Med J [Internet]. 2007;120(1261). PubMed PMID: 17853933.
29. Elley C, Robinson E, Kenealy T, Bramley D, Drury P. Derivation and Validation of a New Cardiovascular Risk Score for People With Type 2 Diabetes. Diabetes Care. 2010;33(6):1347-52.
30. Metcalf P, Wells S, Scragg R, Jackson R. Comparison of three different methods of assesing cardiovascular disease risk in New Zealanders with type 2 diabetes mellitis. N Z Med J. 2008;121(1281):49-57.
31. Riddell T, Wells S, Jackson R, Lee A-W, Crengle S, Bramley D, et al. Performance of Framingham cardiovascualr risk scores by ethnic groups in New Zealand: PREDICT CVD-10. N Z Med J. 2010;123(1309):50-60.
32. Lee E, Howard B, Wang W, Welty T, Galloway J, Best L, et al. Prediction of coronary heart disease in a population with high prevalence of diabetes and albuminuria. The Strong Heart Study. Circulation. 2006;113:2897-905. (Pubitemid 44297230)